scholarly journals Asymptomatic Colonic Metastases of Lung Cancer: A Case Report

2021 ◽  
Vol 16 (5) ◽  
Author(s):  
Pasquale Apolito
Keyword(s):  
Lung Cancer ◽  
Case Report

Intrathoracic Xanthoma Mimicking Lung Cancer in a Patient with Familial Hypercholesterolemia Type II: A Case Report

2007 ◽  
Vol 10 (1) ◽  
pp. E3-E5
Author(s):  
Murat Guvener ◽  
Halil Ucar ◽  
Mustafa Tok ◽  
Omer Dogan ◽  
Isil Yildiz ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Case Report ◽  
Familial Hypercholesterolemia ◽  
Type Ii

Microwave Ablation in Managing Lung Cancer: A Case Report Article Sidebar

2019 ◽  
Vol 15 (1) ◽  
pp. 73-81
Author(s):  
Sawang Saenghirunvattana ◽  
Chittisak Napairee ◽  
Somsak Geraplangsub
Keyword(s):  
Lung Cancer ◽  
Case Report ◽  
Microwave Ablation

scholarly journals Genomic analysis between idiopathic pulmonary fibrosis and associated lung cancer using laser‐assisted microdissection: A case report

2021 ◽  
Author(s):  
Yuko Iida ◽  
Yasuhiro Gon ◽  
Yoko Nakanishi ◽  
Yusuke Kurosawa ◽  
Yoshiko Nakagawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Case Report ◽  
Idiopathic Pulmonary Fibrosis ◽  
Pulmonary Fibrosis ◽  
Genomic Analysis

scholarly journals Febrile neutropenia in a patient with non-small-cell lung cancer treated with atezolizumab: A Case report

2021 ◽  
pp. 101439
Author(s):  
Kyosuke Seguchi ◽  
Kei Nakashima ◽  
Toshiki Terao ◽  
Gaku Takeshita ◽  
Tatsuya Nagai ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Case Report ◽  
Febrile Neutropenia ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals A lung cancer patient with deep vein thrombosis:a case report and literature review

BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Yungu Chen ◽  
Yiu Sing Tsang ◽  
Xiaoxia Chou ◽  
Jiong Hu ◽  
Qing Xia
Keyword(s):  
Lung Cancer ◽  
Case Report ◽  
Literature Review ◽  
Cancer Patient ◽  
Lung Cancer Patient ◽  
Deep Vein

Re-use of erlotinib in a patient using osimertinib after erlotinib, case report

2021 ◽  
pp. 107815522110191
Author(s):  
Pinar Gursoy
Keyword(s):  
Lung Cancer ◽  
Case Report ◽  
Treatment Options ◽  
Resistance Mutation ◽  
Growth Factor Receptor ◽  
Complete Response ◽  
Egfr Mutations ◽  
T790m Mutation ◽  
Development Of Resistance ◽  
Exon 19

Introduction Most patients with non-small-cell lung cancer tumors that have epidermal growth factor receptor (EGFR) mutations have deletion mutations in exon 19 or exon 21, or both.In recent years, targeted therapies in lung cancer have increased survival, but the development of resistance to these drugs poses a major problem. Thesubstitution of methionineforthreonine at position 790 (T790M) mutation,is primarily responsible for this resistance. However, after osimertinib used in T790M positivepatients treatment options are generally limited to chemotherapy. Case report We reported the efficacy of erlotinib, which we reapplied due to the disappearance of the resistance mutation after osimertinib in a 68-year-old patient using osimertinib after erlotinib. Management and outcome: In the patient using erlotinib due to exon 19 deletion when progression was observed and T790M positivity was detected, osimertinib treatment was initiated. However, when T790M was found to be negative with rebiopsy in progression after osimertinib, a complete response was achieved by restarting erlotinib. Discussion The strategy of restarting erlotinib treatment with negative T790M mutation detected in biopsies of patients with osimertinib resistance may be an acceptable treatment option.

Sign in / Sign up

Export Citation Format

Share Document